US Patent Application 18334046. TYPE VI CRISPR ORTHOLOGS AND SYSTEMS simplified abstract
Contents
TYPE VI CRISPR ORTHOLOGS AND SYSTEMS
Organization Name
Massachusetts Institute of Technology
Inventor(s)
Feng Zhang of Cambridge MA (US)
Omar O. Abudayyeh of Cambridge MA (US)
Jonathan Gootenberg of Cambridge MA (US)
Eric S. Lander of Cambridge MA (US)
TYPE VI CRISPR ORTHOLOGS AND SYSTEMS - A simplified explanation of the abstract
This abstract first appeared for US patent application 18334046 titled 'TYPE VI CRISPR ORTHOLOGS AND SYSTEMS
Simplified Explanation
- The patent application is about a new invention related to targeting nucleic acids using non-naturally occurring or engineered RNA-targeting systems. - The invention involves a novel RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component, such as a guide RNA. - The purpose of this invention is to provide improved methods, systems, and compositions for targeting nucleic acids. - The invention is focused on RNA-targeting specifically, which is a specific type of nucleic acid. - The use of non-naturally occurring or engineered RNA-targeting systems suggests that the invention involves synthetic or modified components. - The invention could have potential applications in various fields such as genetic research, gene therapy, or biotechnology.
Original Abstract Submitted
The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered RNA-targeting systems comprising a novel RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA.
